临床儿科杂志 ›› 2026, Vol. 44 ›› Issue (1): 64-70.doi: 10.12372/jcp.2026.25e0166
收稿日期:2025-02-27
录用日期:2025-05-28
出版日期:2026-01-15
发布日期:2026-01-05
通讯作者:
方莹 电子信箱:基金资助:
ZHOU Yuanke1,2, SUN Lina2, FANG Ying2(
)
Received:2025-02-27
Accepted:2025-05-28
Published:2026-01-15
Online:2026-01-05
摘要:
炎症性肠病(IBD)是一种累及全消化道的慢性复发性炎症性疾病,营养素缺乏是IBD患者普遍存在的问题,锌作为人体维持细胞生理功能的重要营养素,在治疗诸多胃肠道疾病方面的益处得到广泛认可。近年来锌与IBD的相关机制研究不断涌现,越来越多的研究揭示了儿童IBD患者普遍存在锌缺乏的情况,缺锌与IBD患儿疾病复发,以及营养不良、生长发育迟缓、贫血等并发症发生有关。本文将回顾IBD与锌相关的基础及临床研究进展,为IBD的机制研究及优化治疗提供参考。
中图分类号:
周圆可, 孙丽娜, 方莹. 锌在儿童炎症性肠病发生发展及治疗中的研究进展[J]. 临床儿科杂志, 2026, 44(1): 64-70.
ZHOU Yuanke, SUN Lina, FANG Ying. Research progress on the role of zinc in the occurrence, development and treatment of inflammatory bowel disease in children[J]. Journal of Clinical Pediatrics, 2026, 44(1): 64-70.
| [1] | 贾双珍, 孔琰, 刘前超, 等. 儿童炎症性肠病的精准治疗研究与应用[J]. 临床儿科杂志, 2025, 43(3): 226-232. |
| Jia SZ, Kong Y, Liu QC, et al. Application of precision therapy in pediatric inflammatory bowel disease[J]. Linchuang Erke Zazhi, 2025, 43(3): 226-232. | |
| [2] | 吴捷, 张添卓. 儿童炎症性肠病的研究现状及展望[J]. 临床儿科杂志, 2023, 41(11): 801-807. |
| Wu J, Zhang TZ. An analysis of the present status and future prospects of pediatric inflammatory bowel disease[J]. Linchuang Erke Zazhi, 2023, 41(11): 801-807. | |
| [3] |
Long D, Wang C, Huang Y, et al. Changing epidemiology of inflammatory bowel disease in children and adolescents[J]. Int J Colorectal Dis, 2024, 39(1): 73.
doi: 10.1007/s00384-024-04640-9 pmid: 38760622 |
| [4] |
Khan R, Kuenzig ME, Benchimol EI. Epidemiology of pediatric inflammatory bowel disease[J]. Gastroenterol Clin North Am, 2023, 52(3): 483-496.
doi: 10.1016/j.gtc.2023.05.001 |
| [5] |
Kuenzig ME, Fung SG, Marderfeld L, et al. Twenty-first century trends in the global epidemiology of pediatric-onset inflammatory bowel disease: systematic review[J]. Gastroenterology, 2022, 162(4): 1147-1159.
doi: 10.1053/j.gastro.2021.12.282 pmid: 34995526 |
| [6] |
Zupo R, Sila A, Castellana F, et al. Prevalence of zinc deficiency in inflammatory bowel disease: a systematic review and meta-analysis[J]. Nutrients, 2022, 14(19): 4052.
doi: 10.3390/nu14194052 |
| [7] |
Peng X, Yang Y, Zhong R, et al. Zinc and inflammatory bowel disease: from clinical study to animal experiment[J]. Biol Trace Elem Res, 2025, 203(2): 624-634.
doi: 10.1007/s12011-024-04193-6 |
| [8] |
Wan Y, Zhang B. The impact of zinc and zinc homeostasis on the intestinal mucosal barrier and intestinal diseases[J]. Biomolecules, 2022, 12(7): 900.
doi: 10.3390/biom12070900 |
| [9] |
Hennigar SR, McClung JP. Zinc transport in the mammalian intestine[J]. Compr Physiol, 2018, 9(1): 59-74.
doi: 10.1002/cphy.c180001 pmid: 30549025 |
| [10] |
Cheng J, Kolba N, Tako E. The effect of dietary zinc and zinc physiological status on the composition of the gut microbiome in vivo[J]. Crit Rev Food Sci Nutr, 2024, 64(18): 6432-6451.
doi: 10.1080/10408398.2023.2169857 |
| [11] |
Costa MI, Sarmento-Ribeiro AB, Gonçalves AC. Zinc: from biological functions to therapeutic potential[J]. Int J Mol Sci, 2023, 24(5): 4822.
doi: 10.3390/ijms24054822 |
| [12] |
Chao HC. Zinc deficiency and therapeutic value of zinc supplementation in pediatric gastrointestinal diseases[J]. Nutrients, 2023, 15(19): 4093.
doi: 10.3390/nu15194093 |
| [13] |
Rezazadegan M, Soheilipour M, Tarrahi MJ, et al. Correlation between zinc nutritional status with serum zonulin and gastrointestinal symptoms in diarrhea-predominant irritable bowel syndrome: a case-control study[J]. Dig Dis Sci, 2022, 67(8): 3632-3638.
doi: 10.1007/s10620-021-07368-6 |
| [14] |
Wang J, Zhao H, Xu Z, et al. Zinc dysregulation in cancers and its potential as a therapeutic target[J]. Cancer Biol Med, 2020, 17(3): 612-625.
doi: 10.20892/j.issn.2095-3941.2020.0106 pmid: 32944394 |
| [15] | Ohashi W, Fukada T. Contribution of zinc and zinc transporters in the pathogenesis of inflammatory bowel diseases[J]. J Immunol Res, 2019, 2019: 8396878. |
| [16] | Mitchell SB, Thorn TL, Lee MT, et al. Metal transporter SLC39A14/ZIP14 modulates regulation between the gut microbiome and host metabolism[J]. Am J Physiol Gastrointest Liver Physiol, 2023, 325(6): G593-G607. |
| [17] |
Govindarasu M, Vaiyapuri M, Kim JC. Protective effect of zinc oxide nanoparticles synthesized using Cassia alata for DSS-induced ulcerative colitis in mice model[J]. Bioprocess Biosyst Eng, 2024, 47(8): 1393-1407.
doi: 10.1007/s00449-024-03047-8 |
| [18] |
Lahiri A, Abraham C. Activation of pattern recognition receptors up-regulates metallothioneins, thereby increasing intracellular accumulation of zinc, autophagy, and bacterial clearance by macrophages[J]. Gastroenterology, 2014, 147(4): 835-846.
doi: 10.1053/j.gastro.2014.06.024 pmid: 24960189 |
| [19] |
Kido T, Ishiwata K, Suka M, et al. Inflammatory response under zinc deficiency is exacerbated by dysfunction of the T helper type 2 lymphocyte-M2 macrophage pathway[J]. Immunology, 2019, 156(4): 356-372.
doi: 10.1111/imm.13033 pmid: 30552817 |
| [20] |
Vaghari-Tabari M, Jafari-Gharabaghlou D, Sadeghsoltani F, et al. Zinc and selenium in inflammatory bowel disease: trace elements with key roles?[J]. Biol Trace Elem Res, 2021, 199(9): 3190-3204.
doi: 10.1007/s12011-020-02444-w pmid: 33098076 |
| [21] |
Wen C, Wang J, Sun Z, et al. Dietary zinc ameliorates TNBS-induced colitis in mice associated with regulation of Th1/Th2/Th17 balance and NF-κB/NLRP3 signaling pathway[J]. Biol Trace Elem Res, 2024, 202(2): 659-670.
doi: 10.1007/s12011-023-03715-y |
| [22] |
Li J, Chen H, Wang B, et al. ZnO nanoparticles act as supportive therapy in DSS-induced ulcerative colitis in mice by maintaining gut homeostasis and activating Nrf2 signaling[J]. Sci Rep, 2017, 7: 43126.
doi: 10.1038/srep43126 pmid: 28233796 |
| [23] |
Shao Y, Wolf PG, Guo S, et al. Zinc enhances intestinal epithelial barrier function through the PI3K/AKT/mTOR signaling pathway in Caco-2 cells[J]. J Nutr Biochem, 2017, 43: 18-26.
doi: S0955-2863(16)30545-9 pmid: 28193579 |
| [24] |
Jarmakiewicz-Czaja S, Ferenc K, Sokal-Dembowska A, et al. Nutritional support: the use of antioxidants in inflammatory bowel disease[J]. Int J Mol Sci, 2024, 25(8): 4390.
doi: 10.3390/ijms25084390 |
| [25] |
Zhang C, Li Q, Xing J, et al. Tannic acid and zinc ion coordination of nanase for the treatment of inflammatory bowel disease by promoting mucosal repair and removing reactive oxygen and nitrogen species[J]. Acta Biomater, 2024, 177: 347-360.
doi: 10.1016/j.actbio.2024.02.015 pmid: 38373525 |
| [26] |
Wu W, Liu L, Zhu Y, et al. Zinc-rutin particles ameliorate DSS-induced acute and chronic colitis via anti-inflammatory and antioxidant protection of the intestinal epithelial barrier[J]. J Agric Food Chem, 2023, 71(34): 12715-12729.
doi: 10.1021/acs.jafc.3c03195 |
| [27] |
Ishihara J, Arai K, Kudo T, et al. Serum zinc and selenium in children with inflammatory bowel disease: a multicenter study in Japan[J]. Dig Dis Sci, 2022, 67(6): 2485-2491.
doi: 10.1007/s10620-021-07078-z |
| [28] |
El Koofy NM, Moawad EMI, Yassin NA, et al. Basic anthropometry, micronutrients status and growth velocity of patients with early-onset inflammatory bowel disease: a prospective cohort study[J]. Arab J Gastroenterol, 2022, 23(4): 270-276.
doi: 10.1016/j.ajg.2022.06.004 pmid: 35918289 |
| [29] |
Ehrlich S, Mark AG, Rinawi F, et al. Micronutrient deficiencies in children with inflammatory bowel diseases[J]. Nutr Clin Pract, 2020, 35(2): 315-322.
doi: 10.1002/ncp.10373 pmid: 31342601 |
| [30] |
Brownson E, Saunders J, Jatkowska A, et al. Micronutrient status and prediction of disease outcome in adults with inflammatory bowel disease receiving biologic therapy[J]. Inflamm Bowel Dis, 2024, 30(8): 1233-1240.
doi: 10.1093/ibd/izad174 |
| [31] |
Fritz J, Walia C, Elkadri A, et al. A systematic review of micronutrient deficiencies in pediatric inflammatory bowel disease[J]. Inflamm Bowel Dis, 2019, 25(3): 445-459.
doi: 10.1093/ibd/izy271 pmid: 30137322 |
| [32] |
Vasseur P, Dugelay E, Benamouzig R, et al. Dietary zinc intake and inflammatory bowel disease in the French NutriNet-Santé cohort[J]. Am J Gastroenterol, 2020, 115(8): 1293-1297.
doi: 10.14309/ajg.0000000000000688 pmid: 32467505 |
| [33] |
Salavatizadeh M, Soltanieh S, Chegini M, et al. Micronutrient intake and risk of ulcerative colitis: a meta-analysis of observational studies[J]. Clin Nutr ESPEN, 2022, 51: 152-159.
doi: 10.1016/j.clnesp.2022.07.008 pmid: 36184199 |
| [34] |
Siva S, Rubin DT, Gulotta G, et al. Zinc deficiency is associated with poor clinical outcomes in patients with inflammatory bowel disease[J]. Inflamm Bowel Dis, 2017, 23(1): 152-157.
doi: 10.1097/MIB.0000000000000989 pmid: 27930412 |
| [35] |
Stochel-Gaudyn A, Fyderek K, Kościelniak P. Serum trace elements profile in the pediatric inflammatory bowel disease progress evaluation[J]. J Trace Elem Med Biol, 2019, 55: 121-126.
doi: S0946-672X(18)30675-8 pmid: 31345349 |
| [36] |
Sakurai K, Furukawa S, Katsurada T, et al. Effectiveness of administering zinc acetate hydrate to patients with inflammatory bowel disease and zinc deficiency: a retrospective observational two-center study[J]. Intest Res, 2022, 20(1): 78-89.
doi: 10.5217/ir.2020.00124 |
| [37] |
Miyaguchi K, Tsuzuki Y, Ichikawa Y, et al. Positive zinc intake and a Japanese diet rich in n-3 fatty acids induces clinical remission in patients with mild active ulcerative colitis: a randomized interventional pilot study[J]. J Clin Biochem Nutr, 2023, 72(1): 82-88.
doi: 10.3164/jcbn.22-72 pmid: 36777083 |
| [38] |
Keshteli AH, Valcheva R, Nickurak C, et al. Anti-inflammatory diet prevents subclinical colonic inflammation and alters metabolomic profile of ulcerative colitis patients in clinical remission[J]. Nutrients, 2022, 14(16): 3294.
doi: 10.3390/nu14163294 |
| [39] | Dragasevic S, Stankovic B, Kotur N, et al. Genetic aspects of micronutrients important for inflammatory bowel disease[J]. Life (Basel), 2022, 12(10): 1623. |
| [40] | 国家卫生健康委员会, 国家中医药管理局. 儿童急性感染性腹泻病诊疗规范(2020年版)[J]. 传染病信息, 2021, 34(1): 7-14. |
| National Health Commission of the People's Republic of China, National Administration of Traditional Chinese Medicine. Guidelines for the diagnosis and treatment of acute infectious diarrhea in children (2020 edition)[J]. Chuanranbing Xinxi, 2021, 34(1): 7-14. | |
| [41] | 儿童锌缺乏症临床防治专家共识编写专家组, 中国研究型医院学会儿科学专业委员会. 儿童锌缺乏症临床防治专家共识[J]. 儿科药学杂志, 2020, 26(3): 46-50. |
| Expert Group for the Development of the Clinical Prevention and Treatment Consensus on Zinc Deficiency in Children, Pediatrics Committee of Chinese Research Hospital Association. Expert consensus on clinical prevention and treatment of zinc deficiency in children[J]. Erke Yaoxue Zazhi, 2020, 26(3): 46-50. |
| [1] | 林锦凤, 陈伊, 邓燕, 冯爱, 黄隽, 陈丽珠, 谢靖麒, 聂晓晶. 化学发光法与细胞间接免疫荧光法检测儿童肾病综合征血清抗Nephrin抗体的比较研究[J]. 临床儿科杂志, 2026, 44(8): 682-689. |
| [2] | 郑方圆, 王淼, 丁明明, 陆爱东, 贾月萍, 曾慧敏, 张乐萍. 儿童费城染色体阳性急性淋巴细胞白血病二代测序基因变异及预后意义的回顾性队列研究[J]. 临床儿科杂志, 2026, 44(8): 690-697. |
| [3] | 张晓, 方红军, 旷小军, 王丽娟, 吴照, 蒋莎, 李佩, 吴丽文. 儿童失张力发作的临床与电生理特征分析[J]. 临床儿科杂志, 2026, 44(8): 698-704. |
| [4] | 王梦倩, 杨辉. 儿童肠型贝赫切特综合征13例病例系列分析[J]. 临床儿科杂志, 2026, 44(8): 705-711. |
| [5] | 吴喜蓉, 高琦, 郭思远, 尹青琴, 秦强, 殷菊, 焦安夏, 陈诚豪, 吴迪, 王蓓, 段晓岷, 彭芸, 徐保平, 高立伟. 儿童糖尿病合并肺毛霉病患者临床特征及预后分析[J]. 临床儿科杂志, 2026, 44(8): 712-720. |
| [6] | 韩亚男, 葛兰兰, 崔洁媛. 1例EYA1基因变异所致鳃-耳-肾综合征患儿的6年诊治及随访报告[J]. 临床儿科杂志, 2026, 44(8): 721-726. |
| [7] | 时嘉仪, 高春林, 贾丽丽, 陆云云, 孙涛, 朱小东, 夏正坤, 张沛. COQ2基因复合杂合突变致儿童孤立性肾病综合征1家系表型特征与预后分析[J]. 临床儿科杂志, 2026, 44(8): 727-732. |
| [8] | 林罗娜, 刘娟娟, 王红玉, 胡波飞, 徐翼, 黄丽素. 儿童流感肺外综合征的发病机制、临床特征与防治:从异位感染到免疫介导损伤[J]. 临床儿科杂志, 2026, 44(8): 733-739. |
| [9] | 贾世辰, 徐国锋. 胱氨酸尿症的诊治进展[J]. 临床儿科杂志, 2026, 44(8): 740-746. |
| [10] | 程于恒, 徐子朝, 陈颖. X-连锁低磷性佝偻病诊疗新进展[J]. 临床儿科杂志, 2026, 44(8): 747-754. |
| [11] | Rachel Rosen, Osvaldo Borrelli, Christophe Faure, Katja Karrento, Usha Krishnan, Samuel Nurko, Nathalie Rommel, Alan Silverman, Michiel van Wijk, Marc Benninga (著), 中华医学会肠外肠内营养学分会儿科学组, 中华医学会儿科学分会消化学组, 中国医师协会儿科医师分会消化学组(译). 罗马Ⅴ诊断标准核心释义与解读:肠-脑互动异常的儿童与青少年上消化道疾病[J]. 临床儿科杂志, 2026, 44(7): 595-608. |
| [12] | Carlo Di Lorenzo, Miguel Saps, Bruno P. Chumpitazi, Shaman Rajindrajith, Annamaria Staiano, Nikhil Thapar, Miranda van Tilburg, Carlos Velasco-Benítez, Arine Vlieger(著), 中华医学会肠外肠内营养学分会儿科学组, 中华医学会儿科学分会消化学组, 中国医师协会儿科医师分会消化学组(译). 罗马Ⅴ诊断标准核心释义与解读:肠-脑互动异常的儿童与青少年下消化道及胆道疾病[J]. 临床儿科杂志, 2026, 44(7): 609-621. |
| [13] | 李旭峰, 唐浩勋, 李兴军, 张立泽, 高晨晴, 赵顺英, 刘建华. 儿童肺炎衣原体肺炎76例临床特点及影像学分型与预后相关性分析[J]. 临床儿科杂志, 2026, 44(7): 622-627. |
| [14] | 王真, 邵静波, 张娜, 夏敏, 朱嘉莳, 杜成坎, 李红. 初诊低危组儿童急性淋巴细胞白血病远期复发影响因素:基于单中心254例患儿的5年随访分析[J]. 临床儿科杂志, 2026, 44(7): 628-635. |
| [15] | 郭雪梅, 薛瑶, 王永韧, 戎留成, 方拥军, 林如峰. 伴CBFA2T3::GLIS2融合基因的儿童急性髓系白血病临床特征及预后分析[J]. 临床儿科杂志, 2026, 44(7): 636-643. |
|
||
沪公网安备 31011002000392号